Rocket Lab (NASDAQ: RKLB) stock has taken off, trading around $64 per share after increasing by more than 330% this year and approximately 520% in the last twelve months. It’s the kind of momentum that attracts serious money, but also profound skepticism. In this video, I will walk you through exact

AI-generated source summary

Rocket Lab Corporation (RKLB) has demonstrated significant market momentum, with its stock appreciating over 150% year-to-date and 466% in the last twelve months, trading at approximately $63.75 per share. Despite a reported negative profit margin of 43%, institutional investors hold a substantial 71.70% of the stock, suggesting a strong level of institutional confidence in its long-term prospects. Morgan Stanley analysts project RKLB could achieve further growth, setting a $68 price target, indicating a 5% potential upside from the current trading levels. This projection is supported by the company's comprehensive 'end-to-end' space capabilities, which include rocket launches, satellite manufacturing, software development, and mission control. Key to its future growth trajectory is the development of the Neutron rocket, a reusable medium-lift vehicle with a payload capacity of 13,000 kg to Low Earth Orbit and 1,500 kg to Mars/Venus. The Neutron is designed for mega-constellation deployments, deep space missions, and human spaceflight, representing a significant advancement over its Electron rocket, which has successfully launched 238 satellites across 72 missions. Rocket Lab's financial performance for Q2 2025 showed total revenue of $144.5 million (GAAP), reflecting a 36% year-over-year growth and 17.9% sequential growth, alongside a GAAP gross margin of 32.1%. A substantial $1 billion backlog, with 58% anticipated to convert to revenue within the next 12 months, further underpins the bullish outlook. The company's strategic initiatives, such as new launch deals and international partnerships, reinforce its market position and potential for continued expansion.

AI-generated summary based on the source content.

Evidence and evaluation progress

1. Original source published

   03 Nov 2025, 23:00 UTC

   The analyst published the original source item.

2. First prediction resolved

   04 Nov 2025, 14:30 UTC

   The first evaluable outcome in this case reached a terminal result.

3. Case evaluation completed

   04 Nov 2025, 14:30 UTC

   All evaluable predictions in this case reached terminal outcomes.

4. Source recorded by Tahlil Plus

   18 May 2026, 20:23 UTC

   The public source was preserved as the evidence record for this case.

5. Market predictions extracted

   18 May 2026, 20:47 UTC

   1 eligible signal linked to this case.

6. Outcome tracking started

   02 Jul 2026, 02:14 UTC

   Tahlil Plus began monitoring the extracted predictions.